✦ LIBER ✦

Blood cell, liver function, and response changes by PEG-interferon-α2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C

✍ Scribed by Ke Ih Kim; Soo Ryang Kim; Noriko Sasase; Yoko Akimoto; Mao Shikata; Aya Ohtani; Teruko Hirooka; Kazuhiko Tanaka

Book ID: 107593730
Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 294 KB
Volume: 2
Category: Article
ISSN: 1936-0533
DOI: 10.1007/s12072-007-9029-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A case of polymyositis in a chronic hepa

A case of polymyositis in a chronic hepatitis C patient treated with peg-interferon-alpha 2b and ribavirin therapy

✍ Yusuke Okuma; Kiminori Kimura; Shunichi Saeki; Tsunekazu Hishima; Seishu Hayashi 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 244 KB

Impact of liver steatosis on virological

Impact of liver steatosis on virological response in elderly Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin

✍ P. Fabris; A. Floreani; A. Carlotto; V. Baldo; L. Bozzola; M. T. Giordani; F. Ne 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Mutations in the interferon sensitivity

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

✍ Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yas 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 266 KB

Changes in serum and red blood cell memb

Changes in serum and red blood cell membrane lipids in patients treated with interferon ribavirin for chronic hepatitis C

✍ H. Tanaka; M. Miyano; H. Ueda; K. Fukui; M. Ichinose 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 119 KB

Pegylated interferon alpha-2b plus ribav

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response

✍ Sanaa M. Kamal; Samer S. El Kamary; Michelle D. Shardell; Mohamed Hashem; Imad N 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated

Changes of liver fibrosis in chronic hep

Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-α therapy: including quantitative assessment by a morphometric method

✍ Michiyasu Yagura; Seiyou Murai; Hiroshi Kojima; Hajime Tokita; Hiroshi Kamitsuka 📂 Article 📅 2000 🏛 Springer Japan 🌐 English ⚖ 504 KB